Cargando…
Are Hepatic Adenomas Premalignant?
Objective: To investigate clinical experience with the apparent malignant transformation of benign liver cell adenomas. Design: Retrospective review of personal experience and literature. Setting: University hospital and affiliated community hospitals. Patients: All patients diagnosed with liver cel...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423828/ https://www.ncbi.nlm.nih.gov/pubmed/9187555 http://dx.doi.org/10.1155/1996/59629 |
_version_ | 1782156190099177472 |
---|---|
author | Nagorney, David M. |
author_facet | Nagorney, David M. |
author_sort | Nagorney, David M. |
collection | PubMed |
description | Objective: To investigate clinical experience with the apparent malignant transformation of benign liver cell adenomas. Design: Retrospective review of personal experience and literature. Setting: University hospital and affiliated community hospitals. Patients: All patients diagnosed with liver cell adenomas over a 30-year period. Interventions: Liver resection and/or tumor biopsy. Main Outcome Measures: Gender, age, drug associations, alpha-fetoprotein levels, response to treatment, and survival. Results: Thirteen patients from personal experience and 26 patients from the reports of others had liver cell adenomas that were not resected. Five of these patients subsequently developed hepatocellular carcinoma. Conclusions: Malignant transformation of a liver cell adenoma is a rare phenomenon, but it does occur. Alphafetoprotein levels may be more helpful in diagnosis than expected from previous reports. Solitary benign adenomas should be resected whenever possible. Patients with diffuse multiple tumors should be observed closely over a long period. |
format | Text |
id | pubmed-2423828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1996 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-24238282008-07-08 Are Hepatic Adenomas Premalignant? Nagorney, David M. HPB Surg Research Article Objective: To investigate clinical experience with the apparent malignant transformation of benign liver cell adenomas. Design: Retrospective review of personal experience and literature. Setting: University hospital and affiliated community hospitals. Patients: All patients diagnosed with liver cell adenomas over a 30-year period. Interventions: Liver resection and/or tumor biopsy. Main Outcome Measures: Gender, age, drug associations, alpha-fetoprotein levels, response to treatment, and survival. Results: Thirteen patients from personal experience and 26 patients from the reports of others had liver cell adenomas that were not resected. Five of these patients subsequently developed hepatocellular carcinoma. Conclusions: Malignant transformation of a liver cell adenoma is a rare phenomenon, but it does occur. Alphafetoprotein levels may be more helpful in diagnosis than expected from previous reports. Solitary benign adenomas should be resected whenever possible. Patients with diffuse multiple tumors should be observed closely over a long period. Hindawi Publishing Corporation 1996 /pmc/articles/PMC2423828/ /pubmed/9187555 http://dx.doi.org/10.1155/1996/59629 Text en Copyright © 1996 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Nagorney, David M. Are Hepatic Adenomas Premalignant? |
title | Are Hepatic Adenomas Premalignant? |
title_full | Are Hepatic Adenomas Premalignant? |
title_fullStr | Are Hepatic Adenomas Premalignant? |
title_full_unstemmed | Are Hepatic Adenomas Premalignant? |
title_short | Are Hepatic Adenomas Premalignant? |
title_sort | are hepatic adenomas premalignant? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423828/ https://www.ncbi.nlm.nih.gov/pubmed/9187555 http://dx.doi.org/10.1155/1996/59629 |
work_keys_str_mv | AT nagorneydavidm arehepaticadenomaspremalignant |